Source: BioPortfolio

Innovus Pharma: Aytu BioScience Enters Agreement to Acquire Innovus Pharmaceuticals

Aytu BioScience NASDAQAYTU has announced that it and Innovus Pharmaceuticals OTCQBINNV have entered into a definitive merger agreement where Aytu will acquire Innovus for up to US$8 millionÂÂin shares of Aytu common stock. As quoted in the press release Th...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Bassam Damaj's photo - President & CEO of Innovus Pharma

President & CEO

Bassam Damaj

CEO Approval Rating

90/100

Read more